ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)
CB8025-31731-RE
Phase 3 other active
Quick answer
ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC) for Primary Biliary Cholangitis is a Phase 3 program (other) at Gilead Sciences International Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gilead Sciences International Limited
- Indication
- Primary Biliary Cholangitis
- Phase
- Phase 3
- Modality
- other
- Status
- active